Eli Lilly said today it will spend $850 million this year on capital projects for its facilities across the U.S., including research laboratories, manufacturing sites, and general and administrative areas.
Lilly said its capital spending...
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) Friday announced its plans
to invest $850 million in its U.S. operations in the year 2017.
The company's investments span facilities across its U.S. enterprise, including
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) announced Monday that its
MONARCH 2 breast cancer Study trial of abemaciclib met the primary endpoint of
progression-free survival. Abemaciclib, in combination with fulvestrant, was
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) announced Saturday that
patients with moderate-to-severe plaque psoriasis treated with Taltz
(ixekizumab) demonstrated superior efficacy at 24 weeks compared to patients
treated with Stelara...